PNP Therapeutics

About:

PNP Therapeutics is engaged in the development of technology and proprietary products for the treatment of cancer.

Website: http://www.pnptherapeutics.com

Top Investors: Georgia Research Alliance, Greer Capital Advisors

Description:

PNP Therapeutics is an early-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. At the center of PNP's Therapeutic System is a patented enzyme (E. coli purine nucleoside phosphorylase) that has been shown to work with a variety of well-characterized nucleoside prodrugs generating active metabolites with high levels of anti-tumor activity.

Total Funding Amount:

$2.59M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Birmingham, Alabama, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)PNPTherapeutics.com

Founders:

Eric Sorscher, William Parker

Number of Employees:

1-10

Last Funding Date:

2019-11-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai